Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Positron Emission Tomography
96%
Fluorine-18
85%
Carbon 11
82%
Neoplasm
67%
Methionine
55%
Positron Emission Tomography
55%
Image Quality
49%
Glioblastoma
36%
Tumor Progression
36%
Fluorodeoxyglucose F 18
35%
Neuroendocrine Tumor
33%
Closed Head Injury
27%
Neuroinflammation
27%
Radioactive Tracer
26%
Polyethylene Terephthalate
24%
Standardized Uptake Value
23%
Parkinsonism
21%
Symptom
19%
Brain Imaging
19%
Systematic Review
18%
Prostate Cancer
18%
Brain Metastasis
18%
Prostate Specific Membrane Antigen
18%
Phenylalanine
18%
Meta-Analysis
18%
Ganglioglioma
18%
Isocitrate Dehydrogenase
18%
Meningioma
18%
Ventricle of Heart
18%
Rapid Eye Movement Sleep Behavior Disorder
18%
Diagnostic Accuracy
18%
Addictive Behavior
18%
Iodine 123
18%
Multiple Sclerosis
18%
Myelin
18%
Mitochondrial Membrane Transport Protein
13%
Chronic Traumatic Encephalopathy
13%
Overall Survival
12%
Degenerative Disease
11%
Clinical Study
11%
Nuclear Medicine
10%
Nuclear Medicine Physician
10%
Neuropsychological Testing
9%
Hypofrontality
9%
Substance Use Disorder
9%
Sequela
9%
Chemical Compound
9%
Traumatic Brain Injury
9%
Striatum
9%
Keyphrases
Pornography Use
18%
Volume-based
18%
PET Parameters
18%
Glioblastoma
18%
Prostate Cancer Patients
18%
Prostate-specific Antigen
18%
Activity Optimization
18%
Prognostic Value
18%
Image Quality Optimization
18%
Isocitrate Dehydrogenase 1 (IDH1)
18%
Repetitive Head Injury
18%
11C-methionine PET
18%
Standardized Uptake Value
18%
Incidental Meningioma
18%
11C-methionine
18%
Nuclear Imaging
18%
Frontotemporal Dementia
18%
Tumor Demarcation
18%
Specific Task
18%
Resting Conditions
18%
Endogenous Levels
18%
Dopamine Transporter
18%
Hyperactivity
18%
Methylphenidate
18%
PET Imaging
18%
Cerebral Glucose Metabolism
18%
Response to Treatment
18%
Childhood-onset
18%
Cerebral Perfusion
18%
Glucose Metabolism
18%
Comorbidity
18%
Genotype
18%
Serotonergic
18%
Neurobiological Basis
18%
Neuropsychiatric Disorders
18%
Single-photon Emission Computed Tomography (SPECT)
18%
Multiple Regions
18%
Prefrontal Cortex
18%
Anterior Cingulate Cortex
18%
Parietal Lobe
18%
Basal Ganglia
18%
Noradrenergic
18%
SPECT Imaging
18%
Dopamine
18%
Impulsivity
18%
Cerebellum
18%
Cognitive Control
18%
Establishing Diagnosis
18%
N-methylation
18%
Myelin Water Imaging
18%
Neuroscience
Positron Emission Tomography
86%
Positron Emission Tomography
82%
Parkinson's Disease
59%
Parkinsonism
46%
Fluorine-18
41%
Methionine
36%
Dopaminergic
29%
Putamen
28%
Single-Photon Emission Computed Tomography
25%
Closed Head Injury
23%
Striatum
23%
Brain Imaging
19%
Magnetic Resonance Imaging
19%
Nucleus Basalis of Meynert
18%
Cholinergic
18%
Eicosanoid Receptor
18%
Iodine-123
18%
Rapid Eye Movement Sleep Behavior Disorder
18%
Raclopride
18%
Attention Deficit Hyperactivity Disorder
18%
Myelin
18%
Multiple Sclerosis
18%
Translocator Protein
13%
Caudate Nucleus
12%
Neurodegenerative Disorder
11%
Impulsivity
9%
Encephalopathy
9%
DOPA
9%
Diffusion Tensor Imaging
6%
In Vivo
6%
Arterial Spin Labeling
6%
Metabolic Pathway
5%
